Q4 2018 Kura Oncology Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2018 Kura Oncology, Inc. Earnings Conference Call. (Operator Instructions) As a reminder, this call may be recorded.
I would now like to introduce your host for today's conference, Pete De Spain, Vice President, Investor Relations. Sir, you may begin.
Thank you, Heather. Good afternoon, and welcome to Kura Oncology's Fourth Quarter and Full Year 2018 Conference Call. Joining me on the call from Kura are Dr. Troy Wilson, our President and Chief Executive Officer; and Dr. Marc Grasso, our Chief Financial Officer and Chief Business Officer. Dr. Antonio Gualberto, our Chief Medical Officer and Head of Development, is also with us and available to answer questions during the Q&A session.
Before I turn the call over to Dr. Wilson, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |